{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:46:01Z","timestamp":1782715561958,"version":"3.54.5"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474399"],"award-info":[{"award-number":["82474399"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405253"],"award-info":[{"award-number":["82405253"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82505444"],"award-info":[{"award-number":["82505444"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2024M750664"],"award-info":[{"award-number":["2024M750664"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"publisher","award":["YDZJ202601ZYTS676"],"award-info":[{"award-number":["YDZJ202601ZYTS676"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005227","name":"Jilin Provincial Department of Health","doi-asserted-by":"publisher","award":["2025WS-KA019"],"award-info":[{"award-number":["2025WS-KA019"]}],"id":[{"id":"10.13039\/501100005227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Myocardial infarction (MI) triggers oxidative stress, mitochondrial dysfunction, and cardiomyocyte apoptosis. At present, it remains urgently needed to develop novel therapies specifically suppressing cardiomyocyte apoptosis via improving mitochondrial dysfunction following MI. Jiedu Huoxue Decoction (JDHXD) may have the effect of ameliorating myocardial injury after MI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study examined the protection exerted by JDHXD against myocardial injury post-MI and investigated the underlying mechanisms of action.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>UHPLC\/Orbitrap-MS, network pharmacology and transcriptome analysis were used to study the effective components and potential targets of JDHXD for treating MI. In vivo: The MI mice received JDHXD (12.74\/25.48\u00a0g\/kg\/day) or captopril treatment for 28\u00a0days. Later, cardiac function (tested by echocardiography and histopathology), apoptosis, oxidative stress, mitochondrial ultrastructure, mitochondrial fission\/fusion and PTEN\/AKT\/GSK3\u03b2 pathway protein levels were evaluated. In vitro: TBHP-induced cardiomyocytes (H9C2 cells and NCMs) were exposed to JDHXD treatment (50\u2013200\u00a0\u03bcg\/mL), with or without PTEN inhibitor Bpv (2\u00a0\u03bcM) or PTEN overexpression (through adenoviral transduction). Afterwards, cell apoptosis, oxidative stress, mitochondrial membrane potential, and relative proteins were assayed. Experiments such as molecular docking and surface plasmon resonance imaging (SPRi) were conducted to verify the effective components of JDHXD in preventing myocardial mitochondrial injury after MI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results of network pharmacology and transcriptomics suggest that JDHXD may ameliorate myocardial injury after MI through modulating PTEN for activating the PI3K\/AKT\/GSK3\u03b2 signaling pathway. In vivo: JDHXD dose-dependently improved left ventricular function, improved the oxidative stress-induced imbalance of mitochondrial fission\/fusion, and inhibited cardiomyocyte apoptosis post-MI in association with suppressing the PTEN\/AKT\/GSK3\u03b2 pathway. In vitro: JDHXD suppressed the TBHP-induced cardiomyocyte apoptosis, attenuated oxidative stress, preserved mitochondrial potential, and restored mitochondrial dynamics. PTEN inhibitor did not augment JDHXD\u2019s effects, whereas PTEN overexpression partially abolished JDHXD\u2019s protection against myocardial injury induced by oxidative stress. UHPLC\/Orbitrap-MS, molecular docking, SPRi and experiments in vitro confirmed that puerarin is one of the main components of JDHXD in regulating the PTEN\/AKT\/GSK3\u03b2 pathway to improve mitochondrial function after MI and inhibit cardiomyocyte apoptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>JDHXD against oxidative stress-induced cardiomyocyte apoptosis post-MI through ameliorating mitochondrial dysfunction, which is partially mediated by suppressing the PTEN\/AKT\/GSK3\u03b2 pathway to inhibit excessive mitochondrial fission and promote mitochondrial fusion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01444-7","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:39:14Z","timestamp":1782707954000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Jiedu Huoxue decoction inhibits cardiomyocyte apoptosis via PTEN\/AKT\/GSK3\u03b2-mediated mitochondrial dynamics in myocardial infarction: an integrative study of network pharmacology, transcriptomics and molecular docking"],"prefix":"10.1186","volume":"21","author":[{"given":"Mingjie","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changlei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzhen","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingpeng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"1444_CR1","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1161\/CIRCULATIONAHA.121.057549","volume":"145","author":"D Jia","year":"2022","unstructured":"Jia D, Chen S, Bai P, Luo C, Liu J, et al. Cardiac resident macrophage-derived legumain improves cardiac repair by promoting clearance and degradation of apoptotic cardiomyocytes after myocardial infarction. Circulation. 2022;145:1542\u201356.","journal-title":"Circulation"},{"key":"1444_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/343268","volume":"2013","author":"HO El-Mesallamy","year":"2013","unstructured":"El-Mesallamy HO, Hamdy NM, El-Etriby AK, Wasfey EF. Plasma granzyme B in ST elevation myocardial infarction versus non-ST elevation acute coronary syndrome: comparisons with IL-18 and fractalkine. Mediat Inflamm. 2013;2013:343268.","journal-title":"Mediat Inflamm."},{"key":"1444_CR3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/eurheartj\/ehaa1012","volume":"42","author":"J Bauersachs","year":"2021","unstructured":"Bauersachs J. Heart failure drug treatment: the fantastic four. Eur Heart J. 2021;42:681\u20133.","journal-title":"Eur Heart J"},{"key":"1444_CR4","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1016\/j.jacc.2014.01.014","volume":"63","author":"IM Seropian","year":"2014","unstructured":"Seropian IM, Toldo S, Van Tassell BW, Abbate A. Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. J Am Coll Cardiol. 2014;63:1593\u2013603.","journal-title":"J Am Coll Cardiol"},{"key":"1444_CR5","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.118.314569","volume":"124","author":"D Jia","year":"2019","unstructured":"Jia D, Jiang H, Weng X, Wu J, Bai P, et al. Interleukin-35 promotes macrophage survival and improves wound healing after myocardial infarction in mice. Circ Res. 2019;124:1323\u201336.","journal-title":"Circ Res"},{"key":"1444_CR6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1161\/CIRCULATIONAHA.119.042532","volume":"141","author":"D Kong","year":"2020","unstructured":"Kong D, Wan Q, Li J, Zuo S, Liu G, Liu Q, et al. DP1 activation reverses age-related hypertension via NEDD4L-mediated T-Bet degradation in T cells. Circulation. 2020;141:655\u201366.","journal-title":"Circulation"},{"key":"1444_CR7","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708237","volume":"10","author":"S Zuo","year":"2018","unstructured":"Zuo S, Kong D, Wang C, Liu J, Wang Y, et al. CRTH2 promotes endoplasmic reticulum stress-induced cardiomyocyte apoptosis through m-calpain. EMBO Mol Med. 2018;10:e8237.","journal-title":"EMBO Mol Med"},{"key":"1444_CR8","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1093\/eurheartj\/ehi419","volume":"26","author":"A Abbate","year":"2005","unstructured":"Abbate A, Bussani R, Biondi Zoccai GG, Santini D, Petrolini A, et al. Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium. Eur Heart J. 2005;26:2039\u201345.","journal-title":"Eur Heart J"},{"key":"1444_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/ejhf.478","volume":"18","author":"VP Harjola","year":"2016","unstructured":"Harjola VP, Mebazaa A, \u010celutkien\u0117 J, et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail. 2016;18:226\u201341.","journal-title":"Eur J Heart Fail"},{"key":"1444_CR10","doi-asserted-by":"publisher","first-page":"13054","DOI":"10.3390\/ijms222313054","volume":"22","author":"S Perveen","year":"2021","unstructured":"Perveen S, Rossin D, Vitale E, et al. Therapeutic acellular scaffolds for limiting left ventricular remodelling-current status and future directions. Int J Mol Sci. 2021;22:13054.","journal-title":"Int J Mol Sci"},{"key":"1444_CR11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tox.2017.07.019","volume":"391","author":"JN Meyer","year":"2017","unstructured":"Meyer JN, Leuthner TC, Luz AL. Mitochondrial fusion, fission, and mitochondrial toxicity. Toxicology. 2017;391:42\u201353.","journal-title":"Toxicology"},{"key":"1444_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102288","volume":"52","author":"C Cai","year":"2022","unstructured":"Cai C, Guo Z, Chang X, et al. Empagliflozin attenuates cardiac microvascular ischemia\/reperfusion through activating the AMPKalpha1\/ULK1\/FUNDC1\/mitophagy pathway. Redox Biol. 2022;52:102288.","journal-title":"Redox Biol"},{"key":"1444_CR13","doi-asserted-by":"publisher","first-page":"H1723","DOI":"10.1152\/ajpheart.00553.2011","volume":"301","author":"S Sanada","year":"2011","unstructured":"Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol. 2011;301:H1723\u201341.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1444_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.yjmcc.2014.09.023","volume":"78","author":"P Bernardi","year":"2015","unstructured":"Bernardi P, Di Lisa F. The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection. J Mol Cell Cardiol. 2015;78:100\u20136.","journal-title":"J Mol Cell Cardiol"},{"key":"1444_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1023\/A:1022945107762","volume":"8","author":"JD Ly","year":"2003","unstructured":"Ly JD, Grubb DR, Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis. 2003;8:115\u201328.","journal-title":"Apoptosis"},{"key":"1444_CR16","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1084\/jem.187.8.1261","volume":"187","author":"I Marzo","year":"1998","unstructured":"Marzo I, Brenner C, Zamzami N, et al. The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J Exp Med. 1998;187:1261\u201371.","journal-title":"J Exp Med"},{"key":"1444_CR17","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a037283","volume":"10","author":"YR Lee","year":"2020","unstructured":"Lee YR, Pandolfi PP. PTEN mouse models of cancer initiation and progression. Cold Spring Harb Perspect Med. 2020;10:a037283.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1444_CR18","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-med-052218-125823","volume":"71","author":"L Yehia","year":"2020","unstructured":"Yehia L, Keel E, Eng C. The clinical spectrum of PTEN mutations. Annu Rev Med. 2020;71:103\u201316.","journal-title":"Annu Rev Med"},{"key":"1444_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114929","volume":"287","author":"X Han","year":"2022","unstructured":"Han X, Zhang G, Chen G, et al. Buyang Huanwu Decoction promotes angiogenesis in myocardial infarction through suppression of PTEN and activation of the PI3K\/Akt signalling pathway. J Ethnopharmacol. 2022;287:114929.","journal-title":"J Ethnopharmacol"},{"key":"1444_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155388","volume":"135","author":"X Han","year":"2024","unstructured":"Han X, Zhang G, Pang M, et al. Taohong siwu decoction suppresses oxidative stress-induced myocardial apoptosis post-myocardial infarction by inhibiting PTEN pathway. Phytomedicine. 2024;135:155388.","journal-title":"Phytomedicine"},{"key":"1444_CR21","doi-asserted-by":"publisher","first-page":"H2402","DOI":"10.1152\/ajpheart.00737.2005","volume":"290","author":"N Ahmad","year":"2006","unstructured":"Ahmad N, Wang Y, Haider KH, et al. Cardiac protection by mitoKATP channels is dependent on Akt translocation from cytosol to mitochondria during late preconditioning. Am J Physiol Heart Circ Physiol. 2006;290:H2402\u20138.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1444_CR22","doi-asserted-by":"publisher","first-page":"H716","DOI":"10.1152\/ajpheart.00455.2011","volume":"302","author":"CC Su","year":"2012","unstructured":"Su CC, Yang JY, Leu HB, Chen Y, Wang PH. Mitochondrial Akt-regulated mitochondrial apoptosis signaling in cardiac muscle cells. Am J Physiol Heart Circ Physiol. 2012;302:H716\u201323.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1444_CR23","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1046\/j.1471-4159.2003.02113.x","volume":"87","author":"GN Bijur","year":"2003","unstructured":"Bijur GN, Jope RS. Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem. 2003;87:1427\u201335.","journal-title":"J Neurochem"},{"key":"1444_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tibs.2003.12.004","volume":"29","author":"RS Jope","year":"2004","unstructured":"Jope RS, Johnson GV. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci. 2004;29:95\u2013102.","journal-title":"Trends Biochem Sci"},{"key":"1444_CR25","doi-asserted-by":"publisher","first-page":"4101738","DOI":"10.1155\/2019\/4101738","volume":"2019","author":"WJ Cai","year":"2019","unstructured":"Cai WJ, Chen Y, Shi LX, et al. AKT-GSK3\u03b2\u00a0signaling pathway regulates mitochondrial dysfunction-associated OPA1 cleavage contributing to osteoblast apoptosis: preventative effects of hydroxytyrosol. Oxid Med Cell Longev. 2019;2019:4101738.","journal-title":"Oxid Med Cell Longev"},{"key":"1444_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0049112","volume":"7","author":"C Chou","year":"2012","unstructured":"Chou C, Lin C, Yang M, et al. GSK3beta-mediated Drp1 phosphorylation induced elongated mitochondrial morphology against oxidative stress. PLoS ONE. 2012;7:e49112.","journal-title":"PLoS ONE"},{"key":"1444_CR27","doi-asserted-by":"publisher","first-page":"H2079","DOI":"10.1152\/ajpheart.00092.2008","volume":"295","author":"K Ohori","year":"2008","unstructured":"Ohori K, Miura T, Tanno M, et al. Ser9 phosphorylation of mitochondrial GSK-3beta is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis. Am J Physiol Heart Circ Physiol. 2008;295:H2079\u201386.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1444_CR28","first-page":"2477","volume":"30","author":"H Luzheng","year":"2012","unstructured":"Luzheng H, Kong G, Gongli H. Influence of Jiedu Huoxue Chinese herbal medicine on MMP-7 and tPA after PCI of acute coronary syndrome. Chin Arch Tradit Chin Med. 2012;30:2477\u20139.","journal-title":"Chin Arch Tradit Chin Med"},{"key":"1444_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.608790","volume":"12","author":"L Long","year":"2021","unstructured":"Long L, Yu Z, Chen S, et al. Pretreatment of Huoxue Jiedu formula ameliorates myocardial ischaemia\/reperfusion injury by decreasing autophagy via activation of the PI3K\/AKT\/mTOR pathway. Front Pharmacol. 2021;12:608790.","journal-title":"Front Pharmacol"},{"key":"1444_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112372","volume":"249","author":"S Gao","year":"2020","unstructured":"Gao S, Zhang Q, Tian C, et al. The roles of Qishen granules recipes, Qingre Jiedu, Wenyang Yiqi and Huo Xue, in the treatment of heart failure. J Ethnopharmacol. 2020;249:112372.","journal-title":"J Ethnopharmacol"},{"key":"1444_CR31","first-page":"77","volume":"43","author":"Y Li","year":"2024","unstructured":"Li Y, Suwen Q, Fanqin H, Duwei Y, Wusheng X. A textual research on the origin of method for detoxification and blood circulation. Beijing J Tradit Chin Med. 2024;43:77\u201381.","journal-title":"Beijing J Tradit Chin Med"},{"key":"1444_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117388","volume":"320","author":"G Zhang","year":"2024","unstructured":"Zhang G, Han X, Xu T, et al. Buyang Huanwu Decoction suppresses cardiac inflammation and fibrosis in mice after myocardial infarction through inhibition of the TLR4 signalling pathway. J Ethnopharmacol. 2024;320:117388.","journal-title":"J Ethnopharmacol"},{"key":"1444_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154748","volume":"114","author":"L Xie","year":"2023","unstructured":"Xie L, Zhou C, Wu Y, et al. Wenqingyin suppresses ferroptosis in the pathogenesis of sepsis-induced liver injury by activating the Nrf2-mediated signaling pathway. Phytomedicine. 2023;114:154748.","journal-title":"Phytomedicine"},{"key":"1444_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/ehf2.13144","volume":"8","author":"D Jen\u010da","year":"2021","unstructured":"Jen\u010da D, Melenovsk\u00fd V, Stehlik J, et al. Heart failure after myocardial infarction: incidence and predictors. ESC Heart Fail. 2021;8:222\u201337.","journal-title":"ESC Heart Fail"},{"key":"1444_CR35","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.1111\/jcmm.15127","volume":"24","author":"SM Davidson","year":"2020","unstructured":"Davidson SM, Adameova A, Barile L, et al. Mitochondrial and mitochondrial-independent pathways of myocardial cell death during ischaemia and reperfusion injury. J Cell Mol Med. 2020;24:3795\u2013806.","journal-title":"J Cell Mol Med"},{"key":"1444_CR36","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/cvr\/cvx049","volume":"113","author":"DJ Hausenloy","year":"2017","unstructured":"Hausenloy DJ, Garcia-Dorado D, B\u00f8tker HE, et al. Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart. Cardiovasc Res. 2017;113:564\u201385.","journal-title":"Cardiovasc Res"},{"key":"1444_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115021","volume":"289","author":"C Fu","year":"2022","unstructured":"Fu C, Wu Y, Liu S, et al. Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K\/AKT\/Nrf2 and SLC7A11\/GPX4 signaling pathway after ischemia. J Ethnopharmacol. 2022;289:115021.","journal-title":"J Ethnopharmacol"},{"key":"1444_CR38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.neulet.2017.02.009","volume":"643","author":"H Hongyun","year":"2017","unstructured":"Hongyun H, Tao G, Pengyue Z, et al. Puerarin provides a neuroprotection against transient cerebral ischemia by attenuating autophagy at the ischemic penumbra in neurons but not in astrocytes. Neurosci Lett. 2017;643:45\u201351.","journal-title":"Neurosci Lett"},{"key":"1444_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2020.113616","volume":"268","author":"HL Li","year":"2021","unstructured":"Li HL, Hao GM, Tang SJ, et al. HuoXue JieDu formula improves diabetic retinopathy in rats by regulating microRNAs. J Ethnopharmacol. 2021;268:113616.","journal-title":"J Ethnopharmacol"},{"key":"1444_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejheart.2006.05.002","volume":"9","author":"J Abdulla","year":"2007","unstructured":"Abdulla J, Barlera S, Latini R, et al. A systematic review: effect of angiotensin converting enzyme inhibition on left ventricular volumes and ejection fraction in patients with a myocardial infarction and in patients with left ventricular dysfunction. Eur J Heart Fail. 2007;9:129\u201335.","journal-title":"Eur J Heart Fail"},{"key":"1444_CR41","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s00395-012-0270-8","volume":"107","author":"MI Oerlemans","year":"2012","unstructured":"Oerlemans MI, Liu J, Arslan F, et al. Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo. Basic Res Cardiol. 2012;107:270.","journal-title":"Basic Res Cardiol"},{"key":"1444_CR42","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.cell.2017.07.050","volume":"170","author":"R Guo","year":"2017","unstructured":"Guo R, Zong S, Wu M, Gu J, Yang M. Architecture of human mitochondrial respiratory megacomplex I2III2IV2. Cell. 2017;170:1247\u201357.","journal-title":"Cell"},{"key":"1444_CR43","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41580-021-00415-0","volume":"23","author":"I Vercellino","year":"2022","unstructured":"Vercellino I, Sazanov LA. The assembly, regulation and function of the mitochondrial respiratory chain. Nat Rev Mol Cell Biol. 2022;23:141\u201361.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1444_CR44","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41569-018-0044-6","volume":"15","author":"E Bertero","year":"2018","unstructured":"Bertero E, Maack C. Metabolic remodelling in heart failure. Nat Rev Cardiol. 2018;15:457\u201370.","journal-title":"Nat Rev Cardiol"},{"key":"1444_CR45","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","volume":"14","author":"DA Brown","year":"2017","unstructured":"Brown DA, Perr JB, Allen ME, et al. Expert consensus document: Mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol. 2017;14:238\u201350.","journal-title":"Nat Rev Cardiol"},{"key":"1444_CR46","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1161\/CIRCRESAHA.116.307505","volume":"118","author":"EJ Lesnefsky","year":"2016","unstructured":"Lesnefsky EJ, Chen Q, Hoppel CL. Mitochondrial metabolism in aging heart. Circ Res. 2016;118:1593\u2013611.","journal-title":"Circ Res"},{"key":"1444_CR47","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1161\/CIRCULATIONAHA.121.056929","volume":"145","author":"R Song","year":"2022","unstructured":"Song R, Dasgupta C, Mulder C, Zhang L. MicroRNA-210 controls mitochondrial metabolism and protects heart function in myocardial infarction. Circulation. 2022;145:1140\u201353.","journal-title":"Circulation"},{"key":"1444_CR48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.gde.2016.03.001","volume":"38","author":"G Wd","year":"2016","unstructured":"Wd G. Mitochondrial fission\/fusion and cardiomyopathy. Curr Opin Genet Dev. 2016;38:38\u201344.","journal-title":"Curr Opin Genet Dev"},{"key":"1444_CR49","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.2337\/db14-0758","volume":"64","author":"S Huang","year":"2015","unstructured":"Huang S, Wang Y, Gan X, et al. Drp1-mediated mitochondrial abnormalities link to synaptic injury in diabetes model. Diabetes. 2015;64:1728\u201342.","journal-title":"Diabetes"},{"key":"1444_CR50","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.redox.2017.01.013","volume":"11","author":"S Rovira-Llopis","year":"2017","unstructured":"Rovira-Llopis S, Ba\u00f1uls C, Diaz-Morales N, et al. Mitochondrial dynamics in type 2 diabetes: pathophysiological implications. Redox Biol. 2017;11:637\u201345.","journal-title":"Redox Biol"},{"key":"1444_CR51","doi-asserted-by":"publisher","first-page":"6571","DOI":"10.1111\/jcmm.15384","volume":"24","author":"S Hernandez-Resendiz","year":"2020","unstructured":"Hernandez-Resendiz S, Prunier F, Girao H, Dorn G, Hausenloy DJ. Targeting mitochondrial fusion and fission proteins for cardioprotection. J Cell Mol Med. 2020;24:6571\u201385.","journal-title":"J Cell Mol Med"},{"key":"1444_CR52","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cmet.2023.01.003","volume":"35","author":"J Suh","year":"2023","unstructured":"Suh J, Kim NK, Shim W, et al. Mitochondrial fragmentation and donut formation enhance mitochondrial secretion to promote osteogenesis. Cell Metab. 2023;35:345-360.e7.","journal-title":"Cell Metab"},{"key":"1444_CR53","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.freeradbiomed.2019.10.413","volume":"146","author":"Y Guo","year":"2020","unstructured":"Guo Y, Wei L, Zhou Y, et al. Flavonoid GL-V9 induces apoptosis and inhibits glycolysis of breast cancer via disrupting GSK-3\u03b2-modulated mitochondrial binding of HKII. Free Radic Biol Med. 2020;146:119\u201329.","journal-title":"Free Radic Biol Med"},{"key":"1444_CR54","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11064-004-2441-y","volume":"30","author":"H Cimarosti","year":"2005","unstructured":"Cimarosti H, Zamin LL, Frozza R, et al. Estradiol protects against oxygen and glucose deprivation in rat hippocampal organotypic cultures and activates Akt and inactivates GSK-3beta. Neurochem Res. 2005;30:191\u20139.","journal-title":"Neurochem Res"},{"key":"1444_CR55","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.yjmcc.2007.08.010","volume":"43","author":"M Nishihara","year":"2007","unstructured":"Nishihara M, Miura T, Miki T, et al. Modulation of the mitochondrial permeability transition pore complex in GSK-3\u03b2-mediated myocardial protection. J Mol Cell Cardiol. 2007;43:564\u201370.","journal-title":"J Mol Cell Cardiol"},{"key":"1444_CR56","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.yjmcc.2005.09.009","volume":"40","author":"S Kaga","year":"2006","unstructured":"Kaga S, Zhan L, Altaf E, Maulik N. Glycogen synthase kinase-3\u03b2\/\u03b2-catenin promotes angiogenic and anti-apoptotic signaling through the induction of VEGF, Bcl-2 and survivin expression in rat ischemic preconditioned myocardium. J Mol Cell Cardiol. 2006;40:138\u201347.","journal-title":"J Mol Cell Cardiol"},{"key":"1444_CR57","doi-asserted-by":"publisher","first-page":"10545","DOI":"10.1158\/0008-5472.CAN-05-1925","volume":"65","author":"JG Pastorino","year":"2005","unstructured":"Pastorino JG, Hoek JB, Shulga N. Activation of glycogen synthase kinase 3\u03b2 disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res. 2005;65:10545\u201354.","journal-title":"Cancer Res"},{"key":"1444_CR58","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1136\/gutjnl-2014-307191","volume":"64","author":"M Soutto","year":"2015","unstructured":"Soutto M, Peng D, Katsha A, et al. Activation of \u03b2-catenin signalling by TFF1 loss promotes cell proliferation and gastric tumorigenesis. Gut. 2015;64:1028\u201339.","journal-title":"Gut"},{"key":"1444_CR59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jare.2024.01.029","volume":"67","author":"W Sun","year":"2025","unstructured":"Sun W, Lei Y, Jiang Z, et al. BPA and low-Se exacerbate apoptosis and mitophagy in chicken pancreatic cells by regulating the PTEN\/PI3K\/AKT\/mTOR pathway. J Adv Res. 2025;67:61\u20139.","journal-title":"J Adv Res"},{"key":"1444_CR60","volume":"13","author":"QQ Wu","year":"2026","unstructured":"Wu QQ, Xiao Y, Hu YY, et al. USP18 exacerbates myocardial I\/R injury by inhibiting Parkin mitophagy through the deubiquitinase PTEN-L. Mil Med Res. 2026;13:100004.","journal-title":"Mil Med Res"},{"key":"1444_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70166","volume":"15","author":"H Zhang","year":"2025","unstructured":"Zhang H, Xu T, Mei X, et al. PINK1 modulates Prdx2 to reduce lipotoxicity-induced apoptosis and attenuate cardiac dysfunction in heart failure mice with a preserved ejection fraction. Clin Transl Med. 2025;15:e70166.","journal-title":"Clin Transl Med"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01444-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01444-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01444-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:04:07Z","timestamp":1782713047000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01444-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1444"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01444-7","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Animal Ethics Committee of Yanbian University approved every experiment (Approval No: YD20250627019; Date: June 27, 2025). Laboratory animals were raised following the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We declare that the publisher has the author\u2019s permission to publish the relevant contribution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}